Eileen Connolly, MD
Radiation Oncology · New York, NYNPI 1730372160
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,800 of the $4,808 with a category attached, or 79.0%. 5 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 53.8% of the total. Reporting peaked in 2019 at $2,563 and has fallen 98.1% since, to $49 in 2025.
Across 9 payments — averaging $534.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$3K
- Davol Inc.$2K
- Abbott$263
- GE HealthCare$109
- Genentech, Inc.$49
Across 12 payments — averaging $93,298 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.1M
- Eisai Inc.$54K
What the payments were for
- Speaking & faculty fees$3,80079%
- Travel & lodging$54311%
- Food & beverage$46610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 4 | $2,587 |
| Davol Inc. | 1 | $1,800 |
| Abbott | 2 | $263 |
| GE HealthCare | 1 | $109 |
| Genentech, Inc. | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,808 in reported general payments places this provider in the 85th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in New York
- Michael ZelefskyNew York$946K
- Nancy LeeNew York$233K
- Robert SamsteinNew York$125K
- Jalal AhmedNew York$100K
- Charles SimoneNew York$84K
- Silvia FormentiNew York$57K
- Brandon ImberNew York$44K
- Himanshu NagarNew York$43K
- Chiaojung TsaiNew York$38K
- Christopher BarkerNew York$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.